SHW
71
3
JNJ
39
-2
CAG
31
-3
FMC
30
-11
DGX
48
-2
AEP
45
-5
MSFT
51
-4
MMC
61
-3
EQT
59
5
ZION
71
3
BEN
40
4
GRMN
71
-2
GIS
25
-3
CHRW
64
13
MAS
60
-2
MU
42
-4
WU
20
-2
PNR
75
4
COST
63
-4
VRTX
62
-6
SHW
71
3
JNJ
39
-2
CAG
31
-3
FMC
30
-11
DGX
48
-2
AEP
45
-5
MSFT
51
-4
MMC
61
-3
EQT
59
5
ZION
71
3
BEN
40
4
GRMN
71
-2
GIS
25
-3
CHRW
64
13
MAS
60
-2
MU
42
-4
WU
20
-2
PNR
75
4
COST
63
-4
VRTX
62
-6
Financhill
Back

enVVeno Medical 10K Form

Sell
35

NVNO
enVVeno Medical

Last Price:
3.49
Seasonality Move:
-9.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVNO News And Ratings

See the #1 stock for the next 7 days that we like better than NVNO

NVNO Financial Statistics

Sales & Book Value

Annual Sales: $31.24K
Cash Flow: $-4.29M
Price / Cash Flow: 0
Annual Sales: $2.70
Price / Book: 1.35

Profitability

EPS (TTM): -1.29000
Net Income (TTM): $-21.24M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

enVVeno Medical Earnings Forecast

Key enVVeno Medical Financial Ratios

  • The Gross Profit Margin over the past 3 years for NVNO is 0.00%.
  • The Selling, General & Administrative Expenses for NVNO have been equal to 15,722.18% of Gross Profit Margin.
  • The Interest Expense is -52.61% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

enVVeno Medical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NVNO
Website: envveno.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVNO Technical Analysis vs Fundamental Analysis

Sell
35
enVVeno Medical (NVNO) is a Sell

Is enVVeno Medical a Buy or a Sell?

  • enVVeno Medical stock is rated a Sell
    The current enVVeno Medical [NVNO] share price is $3.65. The Score for NVNO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.